Theralase Technologies Inc.
TLTFF
$0.1475
$0.00977.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.29% | 4.58% | 17.03% | 11.81% | -28.98% |
| Total Depreciation and Amortization | -7.35% | -2.20% | 2.04% | -2.77% | -4.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.13% | 59.98% | 38.99% | -44.36% | 4.23% |
| Change in Net Operating Assets | 332.26% | 130.67% | -208.52% | 1,328.07% | 90.22% |
| Cash from Operations | 25.83% | 67.51% | -239.20% | 63.40% | 11.63% |
| Capital Expenditure | -818.37% | 22.22% | -950.00% | 77.78% | 67.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -818.37% | 22.22% | -950.00% | 77.78% | 67.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 38.96% | -104.26% | -2.17% | -1.77% | 57.12% |
| Issuance of Common Stock | -32.83% | -65.24% | 75.48% | -37.46% | 6.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33.44% | -69.31% | 78.44% | -39.13% | 10.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.05% | 40.14% | -131.60% | 338.62% | 137.22% |